Recorded device evidence

Fort Defiance Industries FRONT-LINE Field Sterilizer FL120, Fort Defiance Industries FRONT-LINE Field Sterilizer FL135 (K213457): indications, design and recorded evidence

The acquired K213457 file contains product-specific indications and users, design and operating principle, non-clinical evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 28 selected decisions under primary code FLE. 28 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

Calendar elapsed days: lower quartile 92.5, median 136.0, upper quartile 212.2. These are recorded calendar differences, not active FDA review time.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K213457 ↗ · this pageFort Defiance Industries FRONT-LINE Field Sterilizer FL120, Fort Defiance Industries FRONT-LINE Field Sterilizer FL1352021-10-27 → 2022-03-02126Abbreviated
K261055 ↗AMSCO 700 Steam Sterilizer2026-03-31 → 2026-06-2485Traditional
K260254 ↗Enbio PRO2026-01-27 → 2026-02-2630Traditional
K252307 ↗Getinge GSS67N Series Steam Sterilizer2025-07-24 → 2026-01-22182Traditional
K250168 ↗Life Ultra 25L Tabletop Mono Chamber Steam Sterilizer2025-01-21 → 2025-12-30343Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K213457 · PDF page 3 ↗ Source 2

The    Fort Defiance        Industries    FRONT-LINE     Field    Sterilizers      are   autoclaves          designed      for sterilizing   heat-          and  moisture-
stable     medical,      dental,         and  surgical        materials,        including     wrapped   and    unwrapped,           solid,   porous,       and   hollow     items       (e.g.,
dental      handpieces,         suction    pipes)      in    healthcare        facilities.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K213457 · PDF page 6 ↗ Source 3

The Fort Defiance Industries FRONT-LINE Field Sterilizers are autoclaves designed for
      sterilizing heat- and moisture-stable medical, dental, and surgical materials, including
      wrapped and unwrapped, solid, porous, and hollow items (e.g., dental handpieces, suction
      pipes) in healthcare facilities.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Non-clinical evidence actually described

K213457 · PDF page 11 ↗ Source 4

Fort Defiance Industries conducted validation studies in accordance with AAMI/ANSI
              ST55:2016 (FDA Recognition Number 14-518). Design outputs and testing demonstrate
              that the FRONT-LINE Models FL120 and FL135 autoclaves meet all aspects of the
              standard.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK213457 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryFort Defiance Industries FRONT-LINE Field Sterilizer FL120, Fort Defiance Industries FRONT-LINE Field Sterilizer FL135 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantFort Defiance Industries, LLC [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeFLE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2022-03-02 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeAbbreviated [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2021-10-27 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Non-clinical evidence actually described — what differs in our product?

    Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

    Useful evidence: Existing protocols/results and design-specific evidence gaps, with standard editions and scope reviewed separately.

Work packages and dependencies

What needs to happen first

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[118214] · record b5379b0dc5221cc0f1c7a31d3445643c6f2615f693055f1575c3bd7dc4fb214a
  • [5] Complete results array / fda-decision-context:K213457 · record whole dataset partition

FDA 510(k) summary — K213457 ↗

Fri, 04 Mar 2022 05:00:04 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 94483c23b68a0c3a2abb68d99929a4e048df29debc3cae2f8d7e64f9866e8176

  • [2] PDF page 3 · record ceedcaf9cf531770de6c0a0284902991170bfac3e3e86802b86442796ac855d1
  • [3] PDF page 6 · record 3e2d49f0c771a0738b6caaca87d91ceaed089af39dd3a1501308f12fdeebb902
  • [4] PDF page 11 · record 39e7da609ba3326c900291cca3ad80b7a1226f4a96fa36b87c3d475fd47095c3

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services

Sterilization + Microbiology Validation